HR 1262
Mikaela Naylon Give Kids a Chance Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 3:55 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Mikaela Naylon Give Kids a Chance Act aims to improve the FDA’s ability to research and regulate treatments for rare pediatric diseases. It expands the FDA’s authority to enforce pediatric study requirements, reauthorizes funding for pediatric research, and modifies rules regarding orphan drug exclusivity. The bill also includes provisions to streamline the approval process for combination drugs and ensure equitable accountability for pediatric study compliance.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.